A phase Ib/II, open-label, multicenter, randomized umbrella study evaluating the combination of atezolizumab with sacituzumab govitecan in patients with locally advanced or metastatic urothelial carcinoma and previously treated with a platinum-based treatment regimen (MORPHEUS-Urothelial Carcinoma).
- DOI
- 10.1016/j.esmoop.2026.108303
- Published
- 2026 Aug
- Container
- ESMO open
- Publisher
- Not recorded
- Open access
- yes
Credibility signals
limited evidence Score 45/100 under policy 1.0.0. This is a metadata assessment, not a judgment of the paper's conclusions.
Show all credibility signals
- cautionDOI registered: No matching Crossref record was present in this response.
- cautionDOI resolves: No matching Crossref record was present in this response.
- not scoredDirectory of Open Access Journals: No matching DOAJ record was present in this response. No allow-list match; this is not evidence of low credibility.
- not scoredMEDLINE indexed: Not checked or no result supplied; no credibility inference made.
- not scoredOpenAlex core source: Not checked or no result supplied; no credibility inference made.
- not scoredKnown publisher allow-list: Not checked or no result supplied; no credibility inference made.
- not scoredROR affiliation: Not checked or no result supplied; no credibility inference made.
- not scoredRetraction Watch retraction: No retraction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredRetraction Watch expression of concern: No expression of concern notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredRetraction Watch correction: No correction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredRetraction Watch reinstatement: No reinstatement notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- supportingOpen access status: Normalized open-access status: open.
- not scoredPublication license: Not checked or no result supplied; no credibility inference made.
- not scoredPublication version: A publication version was supplied but is not scored.
- cautionMetadata completeness: 5 of 6 scored descriptive metadata groups are present; missing fields increase uncertainty.
Cite this work
BibTeX
@article{allodium:10.1016/j.esmoop.2026.108303,
title = {A phase Ib/II, open-label, multicenter, randomized umbrella study evaluating the combination of atezolizumab with sacituzumab govitecan in patients with locally advanced or metastatic urothelial carcinoma and previously treated with a platinum-based treatment regimen (MORPHEUS-Urothelial Carcinoma).},
author = {Shin SJ and Lee JL and Powles T and Martin-Liberal J and Morales-Barrera R and Drakaki A and Friedlander T and Joly F and Shah SA and Vuky J and Ianculescu I and Michielin F and Gan X and Bamias A},
year = {2026},
journal = {ESMO open},
doi = {10.1016/j.esmoop.2026.108303},
url = {https://doi.org/10.1016/j.esmoop.2026.108303}
}RIS
TY - JOUR TI - A phase Ib/II, open-label, multicenter, randomized umbrella study evaluating the combination of atezolizumab with sacituzumab govitecan in patients with locally advanced or metastatic urothelial carcinoma and previously treated with a platinum-based treatment regimen (MORPHEUS-Urothelial Carcinoma). AU - Shin SJ AU - Lee JL AU - Powles T AU - Martin-Liberal J AU - Morales-Barrera R AU - Drakaki A AU - Friedlander T AU - Joly F AU - Shah SA AU - Vuky J AU - Ianculescu I AU - Michielin F AU - Gan X AU - Bamias A PY - 2026 JO - ESMO open DO - 10.1016/j.esmoop.2026.108303 UR - https://doi.org/10.1016/j.esmoop.2026.108303 ER -
APA
SJ, S., JL, L., T, P., J, M., R, M., A, D., T, F., F, J., SA, S., J, V., I, I., F, M., X, G., & A, B. (2026). A phase Ib/II, open-label, multicenter, randomized umbrella study evaluating the combination of atezolizumab with sacituzumab govitecan in patients with locally advanced or metastatic urothelial carcinoma and previously treated with a platinum-based treatment regimen (MORPHEUS-Urothelial Carcinoma).. ESMO open. https://doi.org/10.1016/j.esmoop.2026.108303
Source records
- pubmed · retrieved 2026-09-25T13:50:57.969Z